Clinical Trials Browser

Phase 2 × Withdrawn × 3-fluorobenzylguanidine × Clear all

NCT06233903 2025-01-21

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Phase 2 Withdrawn

Neuroblastoma, Paraganglioma, Pheochromocytoma